1. Han JC, Lawlor DA, Kimm SY. Childhood obesity. Lancet 2010;375:1737-1748. Epub 2010 May 5
2. de Onis M, Blössner M, Borghi E. Global prevalence and trends of overweight and obesity among preschool children. Am J Clin Nutr 2010;92:1257-1264. Epub 2010 Sep 22
3. Discigil G, Tekin N, Soylemez A. Obesity in Turkish children and adolescents: prevalence and non-nutritional correlates in an urban sample. Child Care Health Dev 2009;35:153-158.
4. Roger VL, Go AS, Lloyd-Jones DM, Benjamin EJ, Berry JD, Borden WB, Bravata DM, Dai S, Ford ES, Fox CS, Fullerton HJ, Gillespie C,Hailpern SM, Heit JA, Howard VJ, Kissela BM, Kittner SJ, Lackland DT, Lichtman JH, Lisabeth LD, Makuc DM, Marcus GM, Marelli A,Matchar DB, Moy CS, Mozaffarian D, Mussolino ME, Nichol G, Paynter NP, Soliman EZ, Sorlie PD, Sotoodehnia N, Turan TN, Virani SS,Wong ND, Woo D, Turner MB; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics-2012 update: a report from the American Heart Association. Circulation 20123;125:2-220. Epub 2011 Dec 15
5. Raitakari OT, Juonala M, Kähönen M, Taittonen L, Laitinen T, Mäki-Torkko N, Järvisalo MJ, Uhari M, Jokinen E, Rönnemaa T, Akerblom HK, Viikari JS. Cardiovascular risk factors in childhood and carotid artery intima-media thickness in adulthood: the Cardiovascular Risk in Young Finns Study. JAMA 2003;290:2277-2283.
6. Berenson GS, Srinivasan SR, Bao W, Newman WP 3rd, Tracy RE, Wattigney WA. Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. The Bogalusa Heart Study. N Engl J Med 1998;338:1650-1656.
7. Steinberger J. Diagnosis of the metabolic syndrome in children. Curr Opin Lipidol 2003;14:555-559.
8. Neyzi O, Günöz H, Furman A, Bundak R, Gökçay G, Darendeliler F. Bas F. Türk çocuklarında vücut ağırlığı, boy uzunluğu, başçevresi ve vücut kitle indeksi referans değerleri. Çocuk Sağlığı ve Hastalıkları Dergisi 2008;51:1-14.
9. Rosenfield RL, Cooke DW, Radovick S. Puberty and Its Disorders in the Female. In: Sperling MA (ed). Pediatric Endocrinology, 2013;569-663.
10. Palmert MR, Dunkel L, Witchel SF. Puberty and Its Disorders in the Male. In: Sperling MA (ed). Pediatric Endocrinology, 2013;697-733.
11. Warnick GR, Knopp RH, Fitzpatrick V, Branson L. Estimating low-density lipoprotein cholesterol by the Friedewald equation is adequate for classifying patients on the basis of nationally recommended cut points. Clin Chem 1990;36:15-19.
12. Daniels SR, Greer FR; Committee on Nutrition. Lipid screening and cardiovascular health in childhood. Pediatrics 2008;122:198-208.
13. Tamir I, Heiss G, Glueck CJ, Christensen B, Kwiterovich P, Rifkind BM. Lipid and lipoprotein distributions in white children ages 6-19 yr. The lipid research clinics program prevalence study. J Chronic Dis 1981;34:27-39.
14. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-419.
15. Valerio G, Licenziati MR, Iannuzzi A, Franzese A, Siani P, Riccardi G, Ruba P. Insulin resistance and impaired glucose tolerance in obese children and adolescents from Southern Italy. Nutr Metab Cardiovasc Dis 2006;16:279-284.
16. Mert A, Kılıç I. Karaciğer Ultrasonografisi, Yağlı Karaciğer, in Ultrasonografiye Giriş Cilt 1-1997.
17. Korsten-Reck U, Kromeyer-Hauschild K, Korsten K, Baumstark MW, Dickhuth HH, Berg A. Frequency of secondary dyslipidemia in obese children. Vasc Health Risk Manag 2008;4:1089-1094.
18. Hashemipour M, Soghrati M, MalekAhmadi M, Soghrati M. Anthropometric indices associated with dyslipidemia in obese children and adolescents: a retrospective study in isfahan. ARYA Atheroscler 2011;7:31-39.
19. Evia-Viscarra ML, Rodea-Montero ER, Apolinar-Jiménez E, Quintana-Vargas S. Metabolic syndrome and its components among obese (BMI >=95th) Mexican adolescents. Endocr Connect 2013;2:208-215.
20. Gong CD, Wu QL, Chen Z, Zhang D, Zhao ZY, Peng YM. Glycolipid metabolic status of overweight/obese adolescents aged 9- to 15-year-old and the BMI-SDS/BMI cut-off value of predicting dyslipidemiain boys, Shanghai, China: a cross-sectional study. Lipids Health Dis 2013;12:129.
21. Cizmecioglu FM, Hatun S, Kalaça S. Metabolic syndrome in obese Turkish children and adolescents: comparison of two diagnostic models. Turk J Pediatr 2008;50:359-365.
22. Freedman DS, Dietz WH, Srinivasan SR, Berenson GS. The relation of overweight to cardiovascular risk factors among children and adolescents: the Bogalusa Heart Study. Pediatrics 1999;103:1175-1182.
23. Yang S, Hwang JS, Park HK, Lee HS, Kim HS, Kim EY, Lim JS. Serum lipid concentrations, prevalence of dyslipidemia, and percentage eligible for pharmacological treatment of Korean children and adolescents; data from the Korea National Health and Nutrition Examination Survey IV (2007-2009). PLoS One 2012;7:49253.
24. Klop B, Elte JW, Cabezas MC. Dyslipidemia in obesity: mechanisms and potential targets. Nutrients 2013;5:1218-1240.
25. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult treatment panel III) final report. Circulation 2002;106:3143-3421.
26. Haas GM, Bertsch T, Schwandt P. Prehypertension and cardiovascular risk factors in children and adolescents participating in the community-based prevention education program family heart study. Int J Prev Med 2014;5(Suppl 1):50-56.
27. Weisell RC. Body mass index as an indicator of obesity. Asia Pacific J Clin Nutr 2002;11(Suppl 7):681-684.
28. Gröber-Grätz D, Widhalm K, de Zwaan M, Reinehr T, Blüher S, Schwab KO, Wiegand S, Holl RW. Body mass index or waist circumference: which is the better predictor for hypertension and dyslipidemia in overweight/obese children and adolescents? Association of cardiovascular risk related to body mass index or waist circumference. Horm Res Paediatr 2013;80:170-178.
29. Holland WL, Bikman BT, Wang LP, Yuguang G, Sargent KM, Bulchand S, Knotts TA, Shui G, Clegg DJ, Wenk MR, Pagliassotti MJ, Scherer PE, Summers SA. Lipid-induced insulin resistance mediated by the proinflammatory receptor TLR4 requires saturated fatty acid-induced ceramide biosynthesis in mice. J Clin Invest 2011;121:1858-1870.
30. Holland WL, Knotts TA, Chavez JA, Wang LP, Hoehn KL, Summers SA. Lipid mediators of insulin resistance. Nutr Rev 2007;65:39-46.
31. Savage DB, Petersen KF, Shulman GI. Disordered lipid metabolism and the pathogenesis of insulin resistance. Physiol Rev 2007;87:507-520.
32. Li N, Fu J, Koonen DP, Kuivenhoven JA, Snieder H, Hofker MH. Are hypertriglyceridemia and low HDL causal factors in the development of insulin resistance? Atherosclerosis 2014;233:130-138. Epub 2014 Jan 7
33. Yoshitomi Y, Ishii T, Kaneki M, Tsujibayashi T, Sakurai S, Nagakura C, Miyauchi A. Relationship between insulin resistance and effect of atorvastatin in non-diabetic subjects. J Atheroscler Thromb 2005;12:9-13.
34. Raitakari OT, Porkka KV, Rönnemaa T, Knip M, Uhari M, Akerblom HK, Viikari JS. The role of insulin in clustering of serum lipids and blood pressure in children and adolescents. The cardiovascular risk in young finns study. Diabetologia 1995;38:1042-1050.
35. Bozic MA, Subbarao G, Molleston JP. Pediatric nonalcoholic fatty liver disease. Nutr Clin Pract 2013;28:448-458.
36. Fu JF, Shi HB, Liu LR, Jiang P, Liang L, Wang CL, Liu XY. Non-alcoholic fatty liver disease: an early mediator predicting metabolic syndrome in obese children? World J Gastroenterol 2011;17:735-742.
37. Arslan N, Büyükgebiz B, Oztürk Y, Cakmakçi H. Fatty liver in obese children: prevalence and correlation with anthropometric measurements and hyperlipidemia. Turk J Pediatr 2005;47:23-27.
38. Chan DF, Li AM, Chu WC, Chan MH, Wong EM, Liu EK, Chan IH, Yin J, Lam CW, Fok TF, Nelson EA. Hepatic steatosis in obese Chinese children. Int J Obes Relat Metab Disord 2004;28:1257-1263.
39. Marras V, Casini MR, Pilia S, Carta D, Civolani P, Porcu M, Uccheddu AP, Loche S. Thyroid function in obese children and adolescents. Horm Res Paediatr 2010;73:193-197. Epub 2010 Mar 3
40. Biondi B. Thyroid and obesity: an intriguing relationship. J Clin Endocrinol Metab 2010;95:3614-3617.
41. Baş VN, Aycan Z, Ağladıoğlu SY, Kendirci HN. Prevalence of hyperthyrotropinemia in obese children before and after weight loss. Eat Weight Disord 2013;18:87-90. Epub 2013 Apr 3
42. Longhi S, Radetti G. Thyroid function and obesity. J Clin
Res Pediatr Endocrinol 2013;5(Suppl 1):40-44. Epub 2012 Nov 1
43. Cordeiro A, Souza LL, Einicker-Lamas M, Pazos-Moura CC. Non-classic thyroid hormone signalling involved in hepatic lipid metabolism. J Endocrinol 2013;216:47-57.
44. Erem C, Değer O, Bostan M, Orem A, Sönmez M, Ulusoy S, Telatar M. Plasma lipoprotein (a) concentrations in hypothyroid, euthyroid and hyperthyroid subjects. Acta Cardiol 1999;54:77-81.
45. Pucci E, Chiovato L, Pinchera A. Thyroid and lipid metabolism. Int J Obes Relat Metab Disord 2000;24(Supll2):109-112.
46. Santos-Palacios S, Brugos-Larumbe A, Guillén-Grima F, Galofré JC. A cross-sectional study of the association between circulating TSH level and lipid profile in a large Spanish population.Clin Endocrinol (Oxf) 2013;79:874-881. Epub 2013 Apr 23
47. Torun E, Özgen IT, Gökçe S, Aydın S, Cesur Y. Thyroid hormone levels in obese children and adolescents with non-alcoholic fatty liver disease. J Clin Res Pediatr Endocrinol 2014;6:34-39.
48. Dullaart RP, van den Berg EH, van der Klauw MM, Blokzijl H. Low normal thyroid function attenuates serum alanine aminotransferase elevations in the context of metabolic syndrome and insulin resistance in white people. Clin Biochem 2014;47:1028-1032. Epub 2014 Apr 21
49. Eshraghian A, Dabbaghmanesh MH, Eshraghian H, Fattahi MR, Omrani GR. Nonalcoholic fatty liver disease in a cluster of Iranian population: thyroid status and metabolic risk factors. Arch Iran Med 2013;16:584-589.